Insufficient scRNA-seq data for expression of DCAF15 at single-cell level.
Insufficient scRNA-seq data for expression of DCAF15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1815.42 | 1445 / 1445 | 100% | 40.86 | 183 / 183 |
ovary | 100% | 1718.11 | 180 / 180 | 100% | 75.84 | 430 / 430 |
uterus | 100% | 2188.89 | 170 / 170 | 100% | 57.04 | 459 / 459 |
thymus | 100% | 2112.32 | 653 / 653 | 100% | 35.26 | 604 / 605 |
intestine | 100% | 2026.56 | 966 / 966 | 99% | 43.87 | 524 / 527 |
skin | 100% | 2719.67 | 1809 / 1809 | 99% | 50.48 | 469 / 472 |
stomach | 100% | 1271.09 | 359 / 359 | 99% | 38.13 | 284 / 286 |
prostate | 100% | 2100.40 | 245 / 245 | 99% | 21.66 | 497 / 502 |
breast | 100% | 2165.34 | 459 / 459 | 99% | 31.51 | 1105 / 1118 |
bladder | 100% | 1768.71 | 21 / 21 | 99% | 44.85 | 498 / 504 |
kidney | 100% | 1727.15 | 89 / 89 | 99% | 23.00 | 890 / 901 |
adrenal gland | 100% | 1172.05 | 257 / 258 | 99% | 34.13 | 228 / 230 |
lung | 100% | 2202.20 | 577 / 578 | 99% | 35.70 | 1140 / 1155 |
brain | 98% | 1365.91 | 2582 / 2642 | 100% | 33.02 | 705 / 705 |
pancreas | 98% | 894.03 | 320 / 328 | 99% | 33.05 | 176 / 178 |
liver | 100% | 839.74 | 225 / 226 | 96% | 19.48 | 389 / 406 |
adipose | 100% | 1826.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 27.24 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 52.91 | 29 / 29 |
spleen | 100% | 3922.64 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 54.58 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 34.94 | 1 / 1 |
blood vessel | 100% | 1552.33 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 1400.30 | 798 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2559.52 | 923 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 1255.21 | 853 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002376 | Biological process | immune system process |
GO_0016567 | Biological process | protein ubiquitination |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0032814 | Biological process | regulation of natural killer cell activation |
GO_0080008 | Cellular component | Cul4-RING E3 ubiquitin ligase complex |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0036094 | Molecular function | small molecule binding |
Gene name | DCAF15 |
Protein name | DDB1 and CUL4 associated factor 15 DDB1- and CUL4-associated factor 15 |
Synonyms | C19orf72 |
Description | FUNCTION: Substrate-recognition component of the DCX(DCAF15) complex, a cullin-4-RING E3 ubiquitin-protein ligase complex that mediates ubiquitination and degradation of target proteins . The DCX(DCAF15) complex acts as a regulator of the natural killer (NK) cells effector functions, possibly by mediating ubiquitination and degradation of cohesin subunits SMC1A and SMC3 . May play a role in the activation of antigen-presenting cells (APC) and their interaction with NK cells . .; FUNCTION: Binding of aryl sulfonamide anticancer drugs, such as indisulam (E7070) or E7820, change the substrate specificity of the DCX(DCAF15) complex, leading to promote ubiquitination and degradation of splicing factor RBM39 . RBM39 degradation results in splicing defects and death in cancer cell lines . Aryl sulfonamide anticancer drugs change the substrate specificity of DCAF15 by acting as a molecular glue that promotes binding between DCAF15 and weak affinity interactor RBM39 . Aryl sulfonamide anticancer drugs also promote ubiquitination and degradation of RBM23 and PRPF39 . . |
Accessions | K7ENG0 ENST00000672437.1 Q66K64 ENST00000591802.1 ENST00000254337.11 K7ELE9 K7ERN0 ENST00000587307.1 ENST00000585468.1 |